Biogen (NASDAQ:BIIB) reported its Q4 earnings results on Thursday, February 3, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Biogen missed estimated earnings by 0.29%, reporting an EPS of $3.39 versus an estimate of $3.4, which did not surprise analysts.
Revenue was up $118.60 million from the same period last year.
Also check out this: Alphabet And 4 Other Stocks Sold By Insiders
Past Earnings Performance
Last quarter the company beat on EPS by $0.66, which was followed by a 1.37% increase in the share price the next day.
Here's a look at Biogen's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 4.11 | 4.55 | 5.04 | 4.87 |
| EPS Actual | 4.77 | 5.68 | 5.34 | 4.58 |
| Revenue Estimate | 2.67B | 2.61B | 2.65B | 2.80B |
| Revenue Actual | 2.78B | 2.77B | 2.69B | 2.85B |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
